Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE)
Part of paid clinical trials in San Diego, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT03980886
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 65 Years
- Healthy Volunteers
- Not accepted
Study Details
Single center observational and specimen banking study for children with eosinophilic esophagitis EoE to gauge natural history and inflammatory markers
Key Dates
- Start date
- Feb 11, 2019
- Status verified
- Jun 2026
- Primary completion
- Dec 17, 2028
- Completion
- Dec 17, 2028
Study Design
- Enrollment
- 1,500 participants (estimated)
Primary Outcome Measure
The longitudinal trajectory of symptoms, endoscopy, and histology in pediatric EoE during routine clinical care [ Time Frame: 10 years ]
Central Contacts
- Kira Chaiboonma, BS8589661700
- Seema S Aceves, MD, PhD8585342983
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rady Children's Hospital San Diego | San Diego | California | 92123 | Seema Aceves, MD.PhD (PRINCIPAL_INVESTIGATOR) Ranjan Dohil, MD (SUB_INVESTIGATOR) Jun Mo, MD (SUB_INVESTIGATOR) Cathleen Collins, MD (SUB_INVESTIGATOR) |
Find similar trials in San Diego, CA
By research site
Related Studies
- OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesRecruiting · Children's Hospital Medical Center, Cincinnati · Phoenix, Arizona
- Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoEPHASE3 · Recruiting · Dr. Falk Pharma GmbH · Scottsdale, Arizona
- A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksPHASE2 · Recruiting · Phathom Pharmaceuticals, Inc. · Little Rock, Arkansas
- Molecular Basis of Food AllergyEnrolling By Invitation · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania